144 0001834021 XXXXXXXX LIVE 0001650648 4D Molecular Therapeutics, Inc. 001-39782 5858 Horton Street Suite 455 Emeryville CA 94608 1-510-505-2680 David Kirn Officer Class A Common Goldman Sachs & Co. LLC 200 West Street New York NY 10282 12923 299942.83 51703412 07/10/2024 NASD Class A Common 12/11/2023 Acquired as compensation -- Stock Options Issuer N 12923 07/10/2024 Compensation -- Cashless exercise / same-day sale N David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608 Class A Common 06/24/2024 8305 191789.5 David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608 Class A Common 06/24/2024 4625 106525.58 The sales of shares set forth herein are made in connection with a selling plan dated 3/21/2024, that is intended to comply with Rule 10b5-1(c). 07/10/2024 03/21/2024 Goldman Sachs & Co. LLC on behalf of David Kirn